20,000 Shares in Intuitive Surgical, Inc. $ISRG Purchased by Davis Rea LTD.

Davis Rea LTD. bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 20,000 shares of the medical equipment provider’s stock, valued at approximately $8,133,000. Intuitive Surgical comprises approximately 2.3% of Davis Rea LTD.’s investment portfolio, making the stock its 13th largest position.

Other institutional investors and hedge funds have also modified their holdings of the company. Invesco Ltd. grew its position in Intuitive Surgical by 17.4% in the fourth quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock valued at $2,338,350,000 after acquiring an additional 611,268 shares during the last quarter. Bank of America Corp DE raised its stake in Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after acquiring an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp bought a new position in shares of Intuitive Surgical in the second quarter worth about $1,335,753,000. Amundi lifted its holdings in shares of Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after acquiring an additional 193,096 shares during the last quarter. Finally, J. Stern & Co. LLP lifted its holdings in shares of Intuitive Surgical by 18,504.6% in the fourth quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock worth $1,204,788,000 after acquiring an additional 2,115,814 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical is expanding beyond core surgery into gastrointestinal care. The company has submitted a next-generation robotic endoscope to the FDA, creating a potential long-term growth avenue if the device is approved and adopted. ISRG Is Expanding Beyond Surgery: Here’s Why the GI Opportunity Matters
• Positive Sentiment: Zacks upgraded ISRG to Rank #2, or “Buy,” citing improving earnings prospects. UBS also reiterated its Buy rating and maintained a $500 price target, supported by the company’s long-term robotic-surgery growth runway. Intuitive Surgical Upgraded to Buy Intuitive Surgical Buy Rating Reiterated
• Positive Sentiment: Erste Group modestly raised its fiscal 2027 earnings forecast to $10.09 per share from $10.06, above the current-year consensus estimate of $8.87. Leerink Partners also maintained its Buy rating. Research Estimates and Ratings
• Neutral Sentiment: Investors are focused on ISRG ahead of its expected quarterly earnings report. The company’s latest results exceeded estimates, with revenue up 18.4% year over year, raising expectations for another solid update but also increasing the risk of disappointment if guidance falls short. Intuitive Surgical Expected to Post Quarterly Earnings
• Negative Sentiment: BTIG lowered its price target to $454 from $469 while retaining a Buy rating. The reduced target may be weighing on sentiment, particularly because ISRG already trades at a high earnings multiple, leaving the stock sensitive to valuation concerns and profit-taking.

Insider Transactions at Intuitive Surgical

In related news, Director Gary S. Guthart sold 10,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total value of $4,000,000.00. Following the completion of the sale, the director directly owned 1,245,679 shares in the company, valued at $498,271,600. This represents a 0.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 1,089 shares of Intuitive Surgical stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $374.44, for a total value of $407,765.16. Following the transaction, the vice president directly owned 1,026 shares in the company, valued at $384,175.44. The trade was a 51.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 12,370 shares of company stock worth $4,891,989. 0.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

ISRG has been the topic of several research reports. Raymond James Financial reaffirmed an “outperform” rating and set a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Barclays upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research report on Wednesday, October 7th. Piper Sandler reissued an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. Citigroup cut their target price on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. Finally, Leerink Partners cut their target price on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a research report on Friday, July 17th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $498.83.

Intuitive Surgical Trading Down 1.3%

ISRG traded down $5.58 on Tuesday, reaching $422.06. The stock had a trading volume of 1,733,011 shares, compared to its average volume of 2,412,700. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The firm has a 50-day moving average of $388.49 and a 200-day moving average of $410.14. The company has a market capitalization of $149.11 billion, a price-to-earnings ratio of 48.35, a price-to-earnings-growth ratio of 3.20 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The business’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period last year, the company earned $1.81 earnings per share. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.